miptec blsw hp 2016 - basel life · 2016. 9. 7. · the basel life science week is becoming a great...
TRANSCRIPT
Basel, Switzerlandwww.basellife.org
FinalProgramme
2
Level Sponsors
A special thank you goes to the congress level sponsors:
Platinum
Gold
Silver
Bronze
Travel grants are sponsored by
And also a special thank you to:
- Industry symposia organisers - Item sponsors- Workshop organisers - Exhibitors- Forum sponsors - Media partners
List current per 22 August 2016
3
Table of Content
Level Sponsors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Welcome Letter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Programme Overview
Monday, 19 September 2016. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Tuesday, 20 September 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Wednesday, 21 September 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
Thursday, 22 September 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Floor Plan Hall 4.0 (Session Rooms) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Detailed Scientifi c Programme
Monday, 19 September 2016. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Tuesday, 20 September 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Wednesday, 21 September 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
Thursday, 22 September 2016 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
Poster Overview (Exhibition, Hall 4.1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
Floor Plan Hall 4.1 (Exhibition) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
Exhibitor List . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
General Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
4
Welcome to the Basel Life Science Week 2016!
Basel Life Science week is an international event with participants from over 45 countries. Our specifi c goal is to catalyse the innovation process amongst creative and passionate individuals. The steering and programme committees invite you to immerse yourself into the programme and help facilitate innovative exchange of ideas and make new networks.
The Basel Life Science Week is becoming a great magnet for life science innovati-on. The 2016 programme will see a convergence of many great offerings – which include: The DayOne programme on Precision Medicine from BaselArea.Swiss, the ILMAC Exhibition on Laboratory Equipment, and the Medical Devices and Diagnostics conference “Medtech&Pharma” - will all take place the same week. You can access all these programmes from links on the Basel Life Science Week homepage (www.basellife.org).
One of the new themes for the 2016 programme is developing open standards for the implementation of Precision Medicine with 3 Forums on “Best Practi-ces”. Digital technology is advancing the delivery of precision medicine and the “Basel Agenda” programme will look at the future of medicine. Drug discovery has always relied on innovative technologies – and Microfl uidics will be in the spotlight this year. Forums on human health (Aging and Infectious diseases); ad-vanced technologies for drug discovery (Stem Cells, Peptide Therapeutics, Protein Production), and focused sessions on Synthetic Biology, Medicinal Chemistry, and Synergy of combination therapies will once again take place.
The MipTec Exhibition on Drug Discovery brings together over 100 vendors to showcase cutting edge technologies that help advance R&D in the life sciences. In 2016, the Product Innovation Award has been expanded to recognize outstan-ding achievement in the development of these technologies. The Innovation-Avenue is a platform for showcase start-ups in life sciences – and this program-me has been extended to enable more start-ups to participate.
For the community, we offer many resources to explore career and personal development. The Jumpstarting Innovations is a day long programme for bud-ding entrepreneurs and Venture Capitalist to meet and exchange ideas. Career training workshops, by renowned Career Coaching professionals, will run before and during the main program of the conference.
The conference continues to evolve and we are in deep gratitude to the countless volunteers involved in the programme development. Our heartfelt thanks to the City of Basel, BaselArea.swiss / INet / Swiss Innovation Park, Messe Basel, and our many sponsors for their continuing support.
We look forward to meeting you at Basel Life Science Week 2016!
Best wishes,
Bhupinder Bhullar, Steering Committee Chair
Gregor Dernick, Programme Chair
Daniel Gygax, Programme Chair
Martin Fussenegger, Scientifi c Advisor
Haike Suering, Exhibitors‘ Representative
Roland Bucher, Exhibitors‘ Representative
Sabine Adam, Congrex Switzerland
Welcome Letter
5
Prog
ram
me
Over
view
Floo
r Pla
n H
all 4
.0Sc
ient
ifi c
Prog
ram
me
Post
erOv
ervi
ewFl
oor P
lan
Hal
l 4.1
Exhi
bito
r Lis
tG
ener
al
Info
rmat
ion
Wel
com
eW
elco
me
Wel
com
eMonday, 19 September 2016
Kairo 1 Kairo 2 Lima09.00
09.15 – 12.45
Career Workshopwith Peggy McKee
09.15 – 12.00
Workshop: Genome Editing
Merck
09.30
10.00
10.30
11.00
11.30
12.00
12.3012.30 – 13.30
Break13.00
13.30
13.45 – 16.00
Career WorkshopPeggy McKee
14.00
14.30
15.00
15.30
Courses & Workshops Industry Symposium Keynote Lecture Networking Events Oral Session Scientifi c Forums
Programme Overview
Prog
ram
me
Over
view
Prog
ram
me
Over
view
p. 13
p. 13
p. 13
6
Tuesday, 20 September 2016
Hall 4.1 Hall 4.1 Delhi Kairo 1 Kairo 2 Shanghai 1 Shanghai 2 Shanghai 3 Boston (1–3) Lima Darwin09.00
08.45 – 18.00Vendor
Exhibition
Coffee is available
during the opening hours
08.45 – 09.15 Welcome Coffee in the exhibition area (Hall 4.1)
08.45 – 09.15 Welcome Coffee in the exhibition area (Hall 4.1)
09.3009.15 – 10.15
Peptide Thera peutics Forum 2016
09.15 – 10.15Stem Cells in Biomedicine
09.15 – 10.15Basel
Agenda09.15 – 10.15
Protein Production
09.15 – 10.15Medicinal
Chemistry and Drug Discovery
10.00
10.00 – 18.00Poster
Exhibition
Running activity throug-hout the
conference
10.3010.15 – 11.00
Coffee Break in the exhibition area (Hall 4.1)10.15 – 11.00
Coffee Break in the exhibition area (Hall 4.1)
11.0011.00 – 12.00
Peptide Thera peutics Forum 2016
11.00 – 12.00Stem Cells in Biomedicine
11.00 – 12.00Basel
Agenda 11.00 – 12.00
Protein Production
11.00 – 12.00Medicinal
Chemistry and Drug Discovery
11.30
12.0012.00 – 13.30
Lunch Break in the exhibition area (Hall 4.1)12.00 – 13.30
Lunch Break in the exhibition area (Hall 4.1)
12.3012.15 – 13.15
Career Workshop
Peggy McKee
12.15 – 13.15Industry Symp
Essen Bioscience
12.15 – 13.15Industry Symp
Czech Republic
13.00
13.30 13.30 – 13.35Welcome WordsBhupinder Bhullar
14.00 13.35 – 14.20Keynote 1
Richard MasonJohnson & Johnson
14.3014.30 – 15.30
Peptide Therapeutics Forum 2016
14.30 – 15.30Stem Cells in Biomedicine
14.30 – 15.30Basel
Agenda14.30 – 15.30
Protein Production
14.30 – 15.30Drug Discovery
Sciences15.00
15.30
15.30 – 16.15Coffee Break in the exhibition area (Hall 4.1)
15.30 – 16.15Coffee Break in the exhibition area (Hall 4.1)16.00
16.3016.15 – 17.15
Peptide Therapeutics Forum 2016
16.15 – 17.15Stem Cells in Biomedicine
16.15 – 17.15Basel
Agenda16.15 – 17.30
Protein Production
16.15 – 17.15Drug Discovery
Sciences17.00
17.30 17.15 – 18.00 Welcome Reception
Hall 4.1
17.15 – 18.00 Welcome Reception
Hall 4.1
Programme Overview
Courses & Workshops Industry Symposium Keynote Lecture Networking Events Oral Session Scientifi c Forums
p. 14
p. 14
p. 14
p. 14
p. 15
p. 15
p. 15
p. 15
p. 16
p. 16
p. 18
p. 16
p. 16
p. 41
7
Prog
ram
me
Over
view
Floo
r Pla
n H
all 4
.0Sc
ient
ifi c
Prog
ram
me
Post
erOv
ervi
ewFl
oor P
lan
Hal
l 4.1
Exhi
bito
r Lis
tG
ener
al
Info
rmat
ion
Wel
com
eTuesday, 20 September 2016
Hall 4.1 Hall 4.1 Delhi Kairo 1 Kairo 2 Shanghai 1 Shanghai 2 Shanghai 3 Boston (1–3) Lima Darwin09.00
08.45 – 18.00Vendor
Exhibition
Coffee is available
during the opening hours
08.45 – 09.15 Welcome Coffee in the exhibition area (Hall 4.1)
08.45 – 09.15 Welcome Coffee in the exhibition area (Hall 4.1)
09.3009.15 – 10.15
Peptide Thera peutics Forum 2016
09.15 – 10.15Stem Cells in Biomedicine
09.15 – 10.15Basel
Agenda09.15 – 10.15
Protein Production
09.15 – 10.15Medicinal
Chemistry and Drug Discovery
10.00
10.00 – 18.00Poster
Exhibition
Running activity throug-hout the
conference
10.3010.15 – 11.00
Coffee Break in the exhibition area (Hall 4.1)10.15 – 11.00
Coffee Break in the exhibition area (Hall 4.1)
11.0011.00 – 12.00
Peptide Thera peutics Forum 2016
11.00 – 12.00Stem Cells in Biomedicine
11.00 – 12.00Basel
Agenda 11.00 – 12.00
Protein Production
11.00 – 12.00Medicinal
Chemistry and Drug Discovery
11.30
12.0012.00 – 13.30
Lunch Break in the exhibition area (Hall 4.1)12.00 – 13.30
Lunch Break in the exhibition area (Hall 4.1)
12.3012.15 – 13.15
Career Workshop
Peggy McKee
12.15 – 13.15Industry Symp
Essen Bioscience
12.15 – 13.15Industry Symp
Czech Republic
13.00
13.30 13.30 – 13.35Welcome WordsBhupinder Bhullar
14.00 13.35 – 14.20Keynote 1
Richard MasonJohnson & Johnson
14.3014.30 – 15.30
Peptide Therapeutics Forum 2016
14.30 – 15.30Stem Cells in Biomedicine
14.30 – 15.30Basel
Agenda14.30 – 15.30
Protein Production
14.30 – 15.30Drug Discovery
Sciences15.00
15.30
15.30 – 16.15Coffee Break in the exhibition area (Hall 4.1)
15.30 – 16.15Coffee Break in the exhibition area (Hall 4.1)16.00
16.3016.15 – 17.15
Peptide Therapeutics Forum 2016
16.15 – 17.15Stem Cells in Biomedicine
16.15 – 17.15Basel
Agenda16.15 – 17.30
Protein Production
16.15 – 17.15Drug Discovery
Sciences17.00
17.30 17.15 – 18.00 Welcome Reception
Hall 4.1
17.15 – 18.00 Welcome Reception
Hall 4.1
Programme Overview
Courses & Workshops Industry Symposium Keynote Lecture Networking Events Oral Session Scientifi c Forums
Prog
ram
me
Over
view
Prog
ram
me
Over
view
p. 17
p. 17
p. 17
p. 17
p. 14
p. 14
p. 18
p. 18
p. 20
p. 18
p. 19
p. 20
p. 41
8
Wednesday, 21 September 2016
Hall 4.1 Hall 4.1 Delhi Kairo 1 Kairo 2 Shanghai 1 Shanghai 2 Shanghai 3 Boston (1–3) Lima09.00
08.45 – 17.00Vendor
Exhibition
Coffee is available during
the opening hours
08.45 – 17.00Poster
Exhibition
Running activity
throughout the conference
08.45 – 09.15Welcome Coffee in the exhibition area (Hall 4.1)
08.45 – 09.15Welcome Coffee in the exhibition area (Hall 4.1)
09.3009.15 – 10.15
Peptide Therapeutics Forum 2016
09.15 – 10.15Jumpstarting Innovation I
09.15 – 10.15Infectious Diseases
09.15 – 10.15Protein
Production
09.15 – 10.15Aging &
Drug Discovery
09.15 – 10.15Best Practices in Clinical and
Research Genomics and Data
Warehousing
10.00
10.3010.15 – 11.00
Coffee Break in the exhibition area (Hall 4.1)10.15 – 11.00
Coffee Break in the exhibition area (Hall 4.1)11.00
11.00 – 12.00Peptide
Therapeutics Forum 2016
11.00 – 12.00Jumpstarting Innovation I
11.00 – 12.00Infectious Diseases
11.00 – 12.00Protein
Production
11.00 – 12.00Aging &
Drug Discovery
11.00 – 12.00Best Practices in Clinical and
Research Genomics and Data
Warehousing
11.30
12.0012.00 – 13.30
Lunch Break in the exhibition area (Hall 4.1)12.00 – 13.30
Lunch Break in the exhibition area (Hall 4.1)12.30
12.15 – 13.15Workshop
Grass & Partners
12.15 – 13.15Industry Symp
PerkinElmer
12.15 – 13.15Industry Symp
Molecular Devices
12.15 – 13.15Industry Symp
Italian Embassy
13.00
13.30
13.30 – 14.15Keynote 2
Susan M. Gasser14.00
14.3014.30 – 15.30
Peptide Therapeutics Forum 2016
14.30 – 15.30Jumpstarting Innovation I
14.30 – 15.30Best practices in genomics data
analysis for clinical and research applications
14.30 – 15.30Protein
Production
14.30 – 15.30Aging &
Drug Discovery
14.30 – 15.30Status and Future of Research Data
Warehouses
14.30 – 15.30Best practices in data storage integrity and
security
15.00
15.30
15.30 – 16.15 Coffee Break in the exhibition area (Hall 4.1)
15.30 – 16.15 Coffee Break in the exhibition area (Hall 4.1)16.00
16.3016.15 – 17.15
Peptide Therapeutics Forum 2016
16.15 – 17.15Jumpstarting Innovation I
16.15 – 17.15Best practices in genomics data
analysis for clinical and research applications
16.15 – 17.30Protein
Production
16.15 – 17.15Aging &
Drug Discovery
16.15 – 17.15Status and Future of Research Data
Warehouses
16.15 – 17.15Best practices in data storage integrity and
security
17.00
17.3017.15 – 18.00 Interactive Poster Session & Apéro
Poster Area Hall 4.117.15 – 18.00 Interactive Poster Session & Apéro
Poster Area Hall 4.118.00
18.00 – 20.00ILMAC exhibitors & get together event in the ILMAC exhibition halls / foyer
18.00 – 20.00ILMAC exhibitors & get together event in the ILMAC exhibition halls / foyer
Courses & Workshops Industry Symposium Keynote Lecture Networking Events Oral Session Scientifi c Forums
Programme Overview
p. 21
p. 21
p. 21
p. 21
p. 22
p. 22
p. 22
p. 22
p. 41
9
Prog
ram
me
Over
view
Floo
r Pla
n H
all 4
.0Sc
ient
ifi c
Prog
ram
me
Post
erOv
ervi
ewFl
oor P
lan
Hal
l 4.1
Exhi
bito
r Lis
tG
ener
al
Info
rmat
ion
Wel
com
eWednesday, 21 September 2016
Hall 4.1 Hall 4.1 Delhi Kairo 1 Kairo 2 Shanghai 1 Shanghai 2 Shanghai 3 Boston (1–3) Lima09.00
08.45 – 17.00Vendor
Exhibition
Coffee is available during
the opening hours
08.45 – 17.00Poster
Exhibition
Running activity
throughout the conference
08.45 – 09.15Welcome Coffee in the exhibition area (Hall 4.1)
08.45 – 09.15Welcome Coffee in the exhibition area (Hall 4.1)
09.3009.15 – 10.15
Peptide Therapeutics Forum 2016
09.15 – 10.15Jumpstarting Innovation I
09.15 – 10.15Infectious Diseases
09.15 – 10.15Protein
Production
09.15 – 10.15Aging &
Drug Discovery
09.15 – 10.15Best Practices in Clinical and
Research Genomics and Data
Warehousing
10.00
10.3010.15 – 11.00
Coffee Break in the exhibition area (Hall 4.1)10.15 – 11.00
Coffee Break in the exhibition area (Hall 4.1)11.00
11.00 – 12.00Peptide
Therapeutics Forum 2016
11.00 – 12.00Jumpstarting Innovation I
11.00 – 12.00Infectious Diseases
11.00 – 12.00Protein
Production
11.00 – 12.00Aging &
Drug Discovery
11.00 – 12.00Best Practices in Clinical and
Research Genomics and Data
Warehousing
11.30
12.0012.00 – 13.30
Lunch Break in the exhibition area (Hall 4.1)12.00 – 13.30
Lunch Break in the exhibition area (Hall 4.1)12.30
12.15 – 13.15Workshop
Grass & Partners
12.15 – 13.15Industry Symp
PerkinElmer
12.15 – 13.15Industry Symp
Molecular Devices
12.15 – 13.15Industry Symp
Italian Embassy
13.00
13.30
13.30 – 14.15Keynote 2
Susan M. Gasser14.00
14.3014.30 – 15.30
Peptide Therapeutics Forum 2016
14.30 – 15.30Jumpstarting Innovation I
14.30 – 15.30Best practices in genomics data
analysis for clinical and research applications
14.30 – 15.30Protein
Production
14.30 – 15.30Aging &
Drug Discovery
14.30 – 15.30Status and Future of Research Data
Warehouses
14.30 – 15.30Best practices in data storage integrity and
security
15.00
15.30
15.30 – 16.15 Coffee Break in the exhibition area (Hall 4.1)
15.30 – 16.15 Coffee Break in the exhibition area (Hall 4.1)16.00
16.3016.15 – 17.15
Peptide Therapeutics Forum 2016
16.15 – 17.15Jumpstarting Innovation I
16.15 – 17.15Best practices in genomics data
analysis for clinical and research applications
16.15 – 17.30Protein
Production
16.15 – 17.15Aging &
Drug Discovery
16.15 – 17.15Status and Future of Research Data
Warehouses
16.15 – 17.15Best practices in data storage integrity and
security
17.00
17.3017.15 – 18.00 Interactive Poster Session & Apéro
Poster Area Hall 4.117.15 – 18.00 Interactive Poster Session & Apéro
Poster Area Hall 4.118.00
18.00 – 20.00ILMAC exhibitors & get together event in the ILMAC exhibition halls / foyer
18.00 – 20.00ILMAC exhibitors & get together event in the ILMAC exhibition halls / foyer
Courses & Workshops Industry Symposium Keynote Lecture Networking Events Oral Session Scientifi c Forums
Programme Overview
p. 22
p. 23
p. 25
p. 25
p. 26
p. 23
p. 23
p. 23
p. 23
p. 27
p. 24
p. 24
p. 24
p. 24
p. 27
p. 26
p. 26
p. 41
p. 27
p. 25
p. 25
p. 21
p. 26
p. 26
Prog
ram
me
Over
view
Prog
ram
me
Over
view
10
Thursday, 22 September 2016
Hall 4.1 Hall 4.1 Delhi Kairo 1 Kairo 2 Shanghai 1 Shanghai 2 Shanghai 3 Boston (1–3) Lima Darwin09.00
08.45 – 16.30Vendor
Exhibition
Coffee is available during
the opening hours
09.00 – 16.00Poster
Exhibition
Running activity
throughout the conference
08.45 – 09.15 Welcome Coffee in the exhibition area (Hall 4.1)
08.45 – 09.15 Welcome Coffee in the exhibition area (Hall 4.1)
09.30
09.15 – 10.15Basel
Microfl uidics Workshop
09.15 – 10.15Best practices in genomics
data analysis for clinical and research applications
09.15 – 10.15Molecluar Diagnostics
09.15 – 10.15Synthetic biology
09.15 – 10.15Aging &
Drug Discovery
09.15 – 10.15Status and Future of Research
Data Warehouses
09.15 – 10.15Synergy Forum
09.15 – 10.15Best
practices in data storage integrity and
security
10.00
10.3010.15 – 11.00
Coffee Break in the exhibition area (Hall 4.1)10.15 – 11.00
Coffee Break in the exhibition area (Hall 4.1)
11.00
11.00 – 12.00Basel
Microfl uidics Workshop
11.00 – 12.00Best practices in genomics
data analysis for clinical and research applications
11.00 – 12.00Molecluar Diagnostics
11.00 – 12.00Synthetic biology
11.00 – 12.00Aging &
Drug Discovery
11.00 – 12.10Status and Future of Research
Data Warehouses
11.00 – 12.00Synergy Forum
11.00 – 12.00Best
practices in data storage integrity and
security
11.30
12.0012.00 – 13.30
Lunch Break in the exhibition area (Hall 4.1)12.00 – 13.30
Lunch Break in the exhibition area (Hall 4.1)
12.30
12.15 – 13.15Workshop
Grass & Partners
13.00
13.30
13.30 – 14.15Keynote 3
Dr. Shai Silberberg
14.00
14.30
14.30 – 15.30Basel
Microfl uidics Workshop
14.30 – 15.30Jumpstarting Innovation II
14.30 – 15.30 Synthetic biology
14.30 – 15.30Aging &
Drug Discovery
14.30 – 15.30Best Practices
in Clinical and Research
Genomics and Data
Warehousing
14.30 – 15.30Synergy Forum15.00
15.3015.30 – 16.15
Coffee Break in the exhibition area (Hall 4.1)15.30 – 16.15
Coffee Break in the exhibition area (Hall 4.1)
16.00
16.15 – 17.15Basel
Microfl uidics Workshop
16.15 – 17.15Jumpstarting Innovation II
16.15 – 17.15Synthetic biology
16.15 – 17.15Aging &
Drug Discovery
16.15 – 17.15Best Practices
in Clinical and Research
Genomics and Data
Warehousing
16.15 – 17.15Synergy Forum16.30
Programme Overview
Courses & Workshops Industry Symposium Keynote Lecture Networking Events Oral Session Scientifi c Forums
p. 28
p. 28
p. 28
p. 29
p. 33
p. 33
p. 35
p. 35
11
Prog
ram
me
Over
view
Floo
r Pla
n H
all 4
.0Sc
ient
ifi c
Prog
ram
me
Post
erOv
ervi
ewFl
oor P
lan
Hal
l 4.1
Exhi
bito
r Lis
tG
ener
al
Info
rmat
ion
Wel
com
eThursday, 22 September 2016
Hall 4.1 Hall 4.1 Delhi Kairo 1 Kairo 2 Shanghai 1 Shanghai 2 Shanghai 3 Boston (1–3) Lima Darwin09.00
08.45 – 16.30Vendor
Exhibition
Coffee is available during
the opening hours
09.00 – 16.00Poster
Exhibition
Running activity
throughout the conference
08.45 – 09.15 Welcome Coffee in the exhibition area (Hall 4.1)
08.45 – 09.15 Welcome Coffee in the exhibition area (Hall 4.1)
09.30
09.15 – 10.15Basel
Microfl uidics Workshop
09.15 – 10.15Best practices in genomics
data analysis for clinical and research applications
09.15 – 10.15Molecluar Diagnostics
09.15 – 10.15Synthetic biology
09.15 – 10.15Aging &
Drug Discovery
09.15 – 10.15Status and Future of Research
Data Warehouses
09.15 – 10.15Synergy Forum
09.15 – 10.15Best
practices in data storage integrity and
security
10.00
10.3010.15 – 11.00
Coffee Break in the exhibition area (Hall 4.1)10.15 – 11.00
Coffee Break in the exhibition area (Hall 4.1)
11.00
11.00 – 12.00Basel
Microfl uidics Workshop
11.00 – 12.00Best practices in genomics
data analysis for clinical and research applications
11.00 – 12.00Molecluar Diagnostics
11.00 – 12.00Synthetic biology
11.00 – 12.00Aging &
Drug Discovery
11.00 – 12.10Status and Future of Research
Data Warehouses
11.00 – 12.00Synergy Forum
11.00 – 12.00Best
practices in data storage integrity and
security
11.30
12.0012.00 – 13.30
Lunch Break in the exhibition area (Hall 4.1)12.00 – 13.30
Lunch Break in the exhibition area (Hall 4.1)
12.30
12.15 – 13.15Workshop
Grass & Partners
13.00
13.30
13.30 – 14.15Keynote 3
Dr. Shai Silberberg
14.00
14.30
14.30 – 15.30Basel
Microfl uidics Workshop
14.30 – 15.30Jumpstarting Innovation II
14.30 – 15.30 Synthetic biology
14.30 – 15.30Aging &
Drug Discovery
14.30 – 15.30Best Practices
in Clinical and Research
Genomics and Data
Warehousing
14.30 – 15.30Synergy Forum15.00
15.3015.30 – 16.15
Coffee Break in the exhibition area (Hall 4.1)15.30 – 16.15
Coffee Break in the exhibition area (Hall 4.1)
16.00
16.15 – 17.15Basel
Microfl uidics Workshop
16.15 – 17.15Jumpstarting Innovation II
16.15 – 17.15Synthetic biology
16.15 – 17.15Aging &
Drug Discovery
16.15 – 17.15Best Practices
in Clinical and Research
Genomics and Data
Warehousing
16.15 – 17.15Synergy Forum16.30
Programme Overview
Courses & Workshops Industry Symposium Keynote Lecture Networking Events Oral Session Scientifi c Forums
p. 29
p. 29
p. 36
p. 30
p. 30
p. 30
p. 30
p. 31
p. 31
p. 31
p. 31
p. 33
p. 33
p. 34
p. 34
p. 28
p. 32
p. 32
p. 32
p. 32
p. 34
p. 34
Prog
ram
me
Over
view
Prog
ram
me
Over
view
12
Floor Plan Hall 4.0 (Session Rooms)
Shanghai 1
Boston 1–3
Darwin
Shanghai 2+3
Overview Hall 4.0 (Session Rooms)
Delhi
Main entrance Speakers’ Service Centre
Secretariat
Kairo 1+2
Lima
2016 Sept 19–23
Posters
KeyNotes
Workshops
ForumsCourses
Sept 19–22
Science Week Leading in Europe
The International Life Science
Exhibition
Sept 20–22
Competence in Process and Laboratory Technology
Sept 20–23 Sept 22–23
Innovative drug-device combinations & diagnostics
Conference ExhibitionPartnering
You are here
13
Scientifi c Programme Monday, 19.09.2016
Prog
ram
me
Over
view
Post
erOv
ervi
ewFl
oor P
lan
Hal
l 4.1
Exhi
bito
r Lis
tG
ener
al
Info
rmat
ion
Wel
com
eSc
ient
ifi c
Prog
ram
me
Workshops and Courses
09.15 – 16.00 Career Workshops with Peggy McKee Kairo 1-2
09.15 LinkedIn – What you should know?P. McKee (Career Confi dential, Gunter, United States)
10.30 Resumes – 3 simple changes to get more interviewsP. McKee (Career Confi dential, Gunter, United States)
11.45 Job search solutions – where are the hidden jobs?P. McKee (Career Confi dential, Gunter, United States)
13.45 Job interviews – how to get more offers?P. McKee (Career Confi dential, Gunter, United States)
15.00 How to get a promotion?P. McKee (Career Confi dential, Gunter, United States)
09.15 – 12.00 Genome Editing: Strategies for Engineering Lima a Model Cell Line
Hosted by Merck
09.15 Genome Editing in Human Stem Cells – Creation of Novel and Relevant Models for Basic Research and Drug DiscoveryM. Gerber (Merck KGaA, Saint Louis, United States)
09.45 Targeted Integration: Nuclease and Donor Design ConsiderationsJ. Gustin (Merck KGaA, Saint Louis, United States)
10.15 Break
10.30 Screening Methods: Basic and AdvancedE. Patterson (Merck KGaA, Saint Louis, United States)
11.15 Special Considerations for iPS/Stem CellsJ. Gustin (Merck KGaA, Saint Louis, United States)
Floo
r Pla
n H
all 4
.0
14
Scientifi c Programme Tuesday, 20.09.2016
Keynote
13.30 – 14.20 Welcome Words Boston 1-3
B. Bhullar (BasePort, Basel, Switzerland)
Keynote Lecture 1
Introduction of the Keynote lectureC. Klöpper (BaselArea.swiss, Switzerland)
Making the connection: the role of collaboration in driving innovation forwardR. Mason (Johnson and Johnson Innovation, London, United Kingdom)
Scientifi c Forums
09.15 – 17.15 Peptide Therapeutics Forum 2016 Delhi
Chairs:E. Kitas (Roche Innovation Center, Basel, Switzerland)R. Stocklin (Atheris SA, Geneva, Switzerland) T. Vorherr (Novartis Pharma AG, Basel, Switzerland)
09.15 Opportunities for chemical protein mimics in vaccine designR. Liskamp (University of Glasgow, United Kingdom)
09.45 Targeting peptides versus proteins by vaccination: size mattersM. Bachmann (University of Berne, Switzerland)
10.15 Coffee break
11.00 A chemical space approach to discover novel antimicrobial peptidesJ.-L. Reymond (University of Berne, Switzerland)
11.30 Specifi c inhibition of beta-secretase processing of the Alzheimer’s disease amyloid precursor proteinL. Rajendran (University of Zurich, Switzerland)
14.30 Brain-Shuttle - BACE1 peptide inhibitor conjugates lower brain Aβ levelsE. Kitas (Roche Innovation Center, Basel, Switzerland)
15.00 Recent advances in solid phase peptide synthesisP.D. White (Novabiochem, Merck, Beeston, United Kingdom)
15.30 Coffee break
16.15 Enabling methods for the rapid total chemical synthesis of proteinsO. Seitz (Humboldt University Berlin, Germany)
16.45 Function of human type sialyloligosaccharide for the bioactivity of glycoproteinsY. Kajihara (Chemistry, Osaka University, Toyonaka, Japan)
15
Scientifi c Programme Tuesday, 20.09.2016
Prog
ram
me
Over
view
Floo
r Pla
n H
all 4
.0Po
ster
Over
view
Fl
oor P
lan
Hal
l 4.1
Exhi
bito
r Lis
tG
ener
al
Info
rmat
ion
Wel
com
eSc
ient
ifi c
Prog
ram
me
09.15 – 17.15 Stem Cells in Biomedicine Kairo 1-2
Chairs: R. Heilker (Boehringer Ingelheim, Biberach, Germany)K. Christensen (Roche Innovation Center, Basel, Switzerland)C. Cusulin (Roche Innovation Center, Basel, Switzerland)
09.15 Metabolic regulation of neural stem cellsM. Knobloch (University of Zurich, Switzerland)
09.45 Development of iPSC-based assays for drug development in neuroscience: tauopathies as an entry pointA. Cabrera Socorro (Janssen Pharmaceutica (J&J), Beerse, Belgium)
10.15 Coffee break
11.00 Bioprinted tissue models for substance evaluationM. Rimann (Zurich University of Applied Sciences, Switzerland)
11.20 Application of stem cell glycomics for effi cient generation of de novo iPS cell lines using glycan biomarkersT. Satomaa (Glykos in Finland, Helsinki, Finland)
11.40 Genome editing in human stem cells - creation of novel and relevant models for basic research and drug discoveryM.A. Gerber (Merck KGaA, St Charles, United States)
14.30 Human induced pluripotent stem cell derived bronchial epithelium to model primary ciliary dyskinesiaJ. de Vos (University Hospital of Montpellier, France)
15.00 To be announced
15.30 Coffee break
16.15 Assessment of anti-cancer drug induced cardiotoxicity in human induced pluripotent stem cell (hiPSC) derived cardiomyocytes using a multiparametric approachM. Vlaming (Pluriomics B.V., Leiden, The Netherlands)
16.45 Human iPSC-derived cardiomyocytes: a comparison with primary cells and applications in standard and 3D cell culture modelsC. Zuppinger (University of Berne, Switzerland)
16
Scientifi c Programme Tuesday, 20.09.2016
09.15 – 17.15 Basel Agenda Shanghai 1
Chair: B. Hofrichter (ConCeplus GmbH, Weggis, Switzerland)
09.15 WelcomeB. Hofrichter (ConCeplus GmbH, Weggis, Switzerland)
09.20 Today Winner – A very brief outlookB. Hofrichter (ConCeplus GmbH, Weggis, Switzerland)
09.30 Infl uencing personal health & wellbeing via wearables & health promoting platformsM. Heuer (dacadoo ag, Zürich, Switzerland)
09.45 When consumer health and health care delivery is aligned!R. Schegg (Healthbank, Baar, Switzerland)
10.00 How booking platforms will infl uence patient journeysP. Kersten (Doctena, Brussles, Belgium)
10.15 Coffee break
11.00 New adherence potentials in joint B2C modelsP. Lichtenberg (Visionarity, Basel, Switzerland)
11.15 Panel Discussion
14.30 Setting the SceneA. Ruzicic (INSEAD Alumni Association Switzerland - Healthcare Club, Zurich, Switzerland)
14.45 Bringing greater value to European healthcare systems: Maximizing outcomes and optimizing costsH. Riband (Amgen, Zug, Switzerland)
15.00 How booking platforms will infl uence patient journeysZ. Khayat (MaRS EXCIT, Toronto, Canada)
15.15 Precision medicine & the regulatory challengeT. Senderovitz (Danish Medicines Agency, Copenhagen, Denmark)
15.30 Coffee break
16.15 How can we make type 2 diabetes 13 times cheaper and cure the patients in doing so?B. van Ommen (TNO, Zeist, Netherlands)
16.25 Panel Discussion
17
Scientifi c Programme Tuesday, 20.09.2016
Prog
ram
me
Over
view
Floo
r Pla
n H
all 4
.0Po
ster
Over
view
Fl
oor P
lan
Hal
l 4.1
Exhi
bito
r Lis
tG
ener
al
Info
rmat
ion
Wel
com
eSc
ient
ifi c
Prog
ram
me
09.15 – 17.30 Protein Production – Current challenges Shanghai 2-3 in protein science: from fundamental research to drug development
Chairs: R. Assenberg (Janssen Biologics B.V., Leiden, The Netherlands)T. Huber (Novartis Pharma AG, Basel, Switzerland)I. Hunt (Novartis Phamra AG, Basel, Switzerland)B. Shrestha (Novartis Pharma AG, Basel, Switzerland)
09.15 New approaches in the selection of candidate therapeutic binders with calcium dependent fragment assembly separation technology (CD-FAST)D.J. O’Connell (University College Dublin, Ireland)
09.45 Protein Production – Dealing with the UnpredictableD. McMillan (UCB Pharma, Slough, United Kingdom)
10.15 Coffee break
11.00 Beyond the prokaryotic ribosome: structural and functional insights into eukaryotic and mitochondrial ribosomesN. Ban (ETH Zurich, Switzerland)
11.30 Native mass spectrometry – new perspectives for drug discoveryJ.T.S. Hopper (University of Oxford, OMass Technologies Ltd, United Kingdom)
14.30 Engineering the way to selective inhibition of human Nav1.7: a target for painS. Ahuja (Genentech, Inc. Portland, United States)
15.00 Human integral membrane protein production for structural and functional studies at the SGCA. Quigley (Structural Genomics Consortium, Oxford, United Kingdom)
15.30 Coffee break
16.15 Directed evolution of G protein-coupled receptors: enabling structure-guided drug discoveryM. Schütz (University of Zurich, Switzerland)
16.45 Building a complete picture: kinetics, thermodynamics and structural determination of stabilised G protein-coupled receptorsE. Segala (Heptares, Welwyn Garden City, United Kingdom)
18
Scientifi c Programme Tuesday, 20.09.2016
09.15 – 12.00 Medicinal Chemistry and Drug Discovery Lima
Chairs: G. Grundler (FNHW, Muttenz, Switzerland)D. Gygax (FNHW, Muttenz, Switzerland)
09.15 Beyond affi nity: what enthalpy, entropy, kon and koff can disclose about ligand optimization in drug discoveryG. Klebe (Philipps University Marburg, Germany)
09.45 Discovery of LTX-315 – a potential fi rst-in-class oncolytic peptideB.E. Haug (University of Bergen, Norway)
10.15 Coffee break
11.00 Drug Discovery with Small-Molecule CMRT™ Macrocycles – Design and ExperienceH. Thomas (Cyclenium Pharma Inc., Sherbrooke, Canada)
11.30 Macrocycles addressing challenging therapeutic targets with unmet medical needsD. Obrecht (Polyphor Ltd, Allschwil, Switzerland)
Workshops and Courses
12.15 – 13.15 Career Workshops with Peggy McKee Shanghai 1
Networking for Career SuccessP. McKee (Career Confi dential, Gunter, United States)
Oral Session
14.30 – 17.15 Drug Discovery Sciences Lima
Chair: G. Dernick (Hoffmann-La Roche, Basel, Switzerland)
14.30 S.M.A.R.T. Steroids – NMDA Receptors Modulators Acting As CNS TherapeuticsE. Kudova1, L. Vyklicky2, M. Smidkova1, M. Nekardova1, E. Zbornikova1, M. Balastik2, K. Vales2, P. Mares2, J. Palecek2
1Institute of Organic Chemistry and Biochemistry Academy of Sciences of the Czech Republic, v.v.i., 2Institute of Physiology, Academy of Sciences of the Czech Republic, v.v.i., Prague, Czech Republic
14.45 DIANA assay for ultrasensitive enzyme quantifi cation and inhibitor screeningV. Navratil, J. Schimer, P. Majer, J. Konvalinka, P. SachaInstitute of Organic Chemistry and Biochemistry Academy of Sciences of the Czech Republic, v.v.i., Prague, Czech Republic
19
Scientifi c Programme Tuesday, 20.09.2016
Prog
ram
me
Over
view
Floo
r Pla
n H
all 4
.0Po
ster
Over
view
Fl
oor P
lan
Hal
l 4.1
Exhi
bito
r Lis
tG
ener
al
Info
rmat
ion
Wel
com
eSc
ient
ifi c
Prog
ram
me
15.00 Long fl uorescence lifetime or label-free? A comparative study of high throughput screening methodologies to minimise assay interferencesP. CraggsScreening, Profi ling and Mechanistic Biology, GSK, Stevenage, United Kingdom
15.15 Maldi mass spectrometry: a label-free solution for ultra-high-throughput screeningM. Hamester, J. Fuchser, F.J. Mayer, V. SauerlandMass Spectrometry, Bruker Daltonics, Bremen, Germany
15.30 Coffee Break
16.15 High-throughput microfl uidic platform for culture of 3D kidney tissue modelsH. Lanz, M. Vormann, A. van den Heuvel, K. Wilschut, C. Ng, R. van Vught, S. Trietsch, J. Joore, P. Vulto, S. QuaderMimetas, Leiden, The Netherlands
16.30 „Structured Confocal”, a new twist for superior 3D live cell imaging in a (smart, compact) boxC. Seebacher1, A. Deeg1, T. Moore2, R. Uhl1
1TILL I.D. GmbH, Martinsried, 2Analytik Jena AG, Jena, Germany
16.45 Quantitative high-content screening methods reveal a regulation of cell-to-cell variability of the energy metabolism of brain cellsG. Azarias1, H. de Castro2, J.-Y. Chatton2, B. Weber1
1Institute of Pharmacology and Toxicology, University of Zurich, Zurich, 2Department of Fundamental Neurosciences, University of Lausanne, Lausanne, Switzerland
17.00 DNA encoded library derived molecule properties and library productivityO. Eidam, A.L. SatzRoche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
20
Scientifi c Programme Tuesday, 20.09.2016
Industry Symposia
12.15 – 13.15 Embassy of the Czech Republic Darwin Czech Centres of Excellence
Chair: M. Partl (CzechInvest, Düsseldorf, Germany)
12.15 Welcome speechR. Opatril (Embassy Berne, Switzerland)
12.20 Keynote speechH.E.K. Boruvka (Embassy Berne, Switzerland)
12.25 IOCB Drug discovery pipelineJ. Zahrádka (IOCB, Prague, Czech Republic)
12.35 20 years of pharmaceutical researchM. Kořínek (Apigenex, Prague, Czech Republic)
12.45 Functional Genomics ProgrammeR. Sedláček (Czech Centre for Phenogenomics, Prague, Czech Republic)
12.55 Life Sciences in the Czech RepublicH. Chlebna (CzechInvest, Prague, Czech Republic)
12.15 – 13.15 Essen BioScience Lima Learn How to Improve Translation of Phenotypic Assays
Using IncuCyte ZOOM Live-Cell Analysis System
Chair: T. Dale (Essen BioScience, Welwyn Garden City, United Kingdom)
12.15 Introduction to IncuCyte ZOOM® and the concept of long term live cell imagingT. Dale (Essen BioScience, Welwyn Garden City, United Kingdom)
12.20 IncuCyte ZOOM® Applications in Mechanistic SafetyK. Dernick (Roche, Basel, Switzerland)
12.45 Improving the translation of phenotypic assays with IncuCyte ZOOM® live-cell analysisT. Dale (Essen BioScience, Welwyn Garden City, United Kingdom)
13.05 Q&A and networkingT. Dale (Essen BioScience, Welwyn Garden City, United Kingdom)K. Dernick (Roche, Basel, Switzerland)
21
Scientifi c Programme Wednesday, 21.09.2016
Prog
ram
me
Over
view
Floo
r Pla
n H
all 4
.0Po
ster
Over
view
Fl
oor P
lan
Hal
l 4.1
Exhi
bito
r Lis
tG
ener
al
Info
rmat
ion
Wel
com
eSc
ient
ifi c
Prog
ram
me
Keynote
13.30 – 14.15 Welcome Words Boston 1-3
G. Dernick (Hoffmann-La Roche, Basel, Switzerland)
Keynote Lecture 2
Life Sciences today and tomorrowS. Gasser (FMI, Basel, Switzerland)
Scientifi c Forums
09.15 – 17.15 Peptide Therapeutics Forum 2016 Delhi
Chairs: E. Kitas (Roche Innovation Center, Basel, Switzerland)R. Stocklin (Atheris SA, Geneva, Switzerland)T. Vorherr (Novartis Pharma AG, Basel, Switzerland)
09.15 Making connections in peptide chemistryP.E. Dawson (The Scripps Research Institute (TSRI), La Jolla, United States)
09.45 Chemical biology of peptide natural products – structures, syntheses and bioactivitiesR.D. Süssmuth (Technische Universität Berlin, Germany)
10.15 Coffee break
11.00 Oxytocin MimeticsP. Alewood (The University of Queensland, Brisbane, Australia)
11.30 Therapeutic potential of Conus Venom peptidesB.M. Olivera (University of Utah, Salt Lake City, United States)
14.30 Knottins and beyond: mono- and oligovalent constrained peptide inhibitors for biomedical applicationsH. Kolmar (Biochemie TU, Darmstadt, Germany)
15.00 The challenges of targeting RXFP1, the receptor for the heart failure drug candidate serelaxin, with peptide mimetics and small moleculesR.A. Bathgate (Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia)
15.30 Coffee break
16.15 The infl uence of stabilization of peptide therapeutics on their immunogenic potentialT. Schwandt (Roche Innovation Center, Basel, Switzerland)
16.45 XTEN™ protein polymer for half-life extension and tumor drug deliveryV. Schellenberger (Amunix, Mountain View, United States)
22
Scientifi c Programme Wednesday, 21.09.2016
09.15 – 17.15 Jumpstarting Innovation – Early stage Kairo 1-2 investing, start-up-incubation and how to enable the future generation of biotech innovators
Chairs:S. Emmerth (BaselArea.swiss, Basel, Switzerland)B. Bhullar (BasePort, Basel, Switzerland)O. Gusyatiner (IF Lausanne, Switzerland)M. Fankhauser (IF Lausanne, Switzerland)
09.15 New Models in Life Science Investing: Integrating All StakeholdersA. Royston (VenBio, San Francisco, United States)
09.45 To be announced
10.15 Coffee break
11.00 Immusoft CorporationM. Scholz (Immusoft Corporation, Seattle, United States)
11.30 What does it take to be innovative in pharma?O. Krylova (Scouting and Innovative Medicines Initiative External R&D Innovation, United Kingdom)
14.30 The asset-centric business model: the established trend in venture capital investingM. De Boer (Medicxi Ventures, London, United Kingdom)
15.00 Translating Innovative Science from the Laboratory to the PatientS. Minick (Arch Venture Partners, San Francisco, United States)
15.30 Coffee break
16.15 Novel ways for innovators to work collaboratively with the health innovation ecosystem. The MaRS / Canada storyZ. Khayat (MaRS EXCIT, Toronto, Canada)
16.45 Elthera: a novel approach for targeted cancer therapyA. Schmidt (Elthera AG, Zug, Switzerland)
09.15 – 12.00 Infectious Diseases Shanghai 1
Chairs: U. Jenal (University of Basel, Switzerland)D. Ritz (Actelion Pharmaceuticals Ltd., Allschwil, Switzerland)
09.15 Opening Remarks
09.20 Common themes in the evolution of drug resistanceS. Bonhoefer (ETH Zurich, Switzerland)
09.45 Discovery and development of novel macrocycle antibioticsG. Dale (Polyphor Ltd, Allschwil, Switzerland)
10.15 Coffee break
23
Scientifi c Programme Wednesday, 21.09.2016
Prog
ram
me
Over
view
Floo
r Pla
n H
all 4
.0Po
ster
Over
view
Fl
oor P
lan
Hal
l 4.1
Exhi
bito
r Lis
tG
ener
al
Info
rmat
ion
Wel
com
eSc
ient
ifi c
Prog
ram
me
11.00 Phage-Based TherapiesG. Resch (Université de Lausanne, Switzerland)
11.30 Salmonella single-cell dynamics in complex tissuesD. Bumann (Universtiy of Basel, Switzerland)
09.15 – 17.30 Protein Production – Current challenges Shanghai 2 in protein science: from fundamental research to drug development
Chairs:R. Assenberg (Janssen Biologics B.V., Leiden, The Netherlands)T. Huber (Novartis Pharma AG, Basel, Switzerland)I. Hunt (Novartis Phamra AG, Basel, Switzerland)B. Shrestha (Novartis Pharma AG ,Basel, Switzerland)
09.15 The Confo®body technology, a new platform to enable fragment screening on GPCRsC. Menet (VIB, Brussels, Belgium)
09.45 Harnessing the Flexibility of the ExpiCHO Transient Expression System: New Uses, New Protocols and Tips for Optimizing Protein ExpressionH. Chiou (Life Technologies, Themo, Carlsbad, United States)
10.15 Coffee break
11.00 Engineering antibodies for cancer immunotherapyC. Klein (Roche Innovation Center Zurich, Switzerland)
11.30 Therapeutic antibody potentiation by antigen- and Fc-dependent IgG hexamer formation
R.N. de Jong (Genmab, Utrecht, The Netherlands)
14.30 Targeting CD47 in cancer with bispecifi c antibodiesK. Masternak (Novimmune SA, Geneva, Switzerland)
15.00 CAP-Go: novel cell lines for the production of tailor-made glycoproteinsS. Wissing (Cevec, Cologne, Germany)
15.30 Coffee break
16.15 Bispecifi c FynomAbs: Novel modes of action through tailored architectureM. Silacci (Johnson & Johnson, Zurich, Switzerland)
16.45 Enabling the Generation of Multi-Functional Drugs for Ophthalmology and Oncology with DARPins H.K. Binz (Molecular partners, Zurich, Switzerland)
24
Scientifi c Programme Wednesday, 21.09.2016
09.15 – 17.15 Aging & Drug Discovery Shanghai 3
Chairs: A. Zhavoronkov (Insilico Medicine, Baltimore, United States)B. Bhullar (BasePort, Basel, Switzerland)B. Kennedy (Buck Institute for Research on Aging, Novato, United States)
09.15 KeynoteM. West (BioTime Inc., San Francisco, United States)
09.45 KeynoteR. Hariri (Celgene, Human Longevity Inc., New York, United States)
10.15 Coffee break
11.00 Strategies to get aging interventions into humansB. Kennedy (Buck Institute for Research on Aging, Novato, United States)
11.30 Maximising healthy lifespan – a national level priorityR. Barker (Precision Medicine Catapult, Innovate UK, Swindon, United Kingdom)
14.30 The role of INDY in fl y health, metabolism and longevity: a new approach for drug discovery.B. Rogina (University of Connecticut Health/School of Medicine, Farmington, United States)
15.00 Artifi cial intelligence for aging biomarker discovery in Asian populationM.-Y. Wong (Asia Genomics, Ltd, Singapore, Singapore)
15.30 Coffee Break
16.15 Applying actuarial methods to drug sales data to discover insights into longevity interventionsE. Debonneuil (ActuRx and Blue Antidote, Paris, France)A. Terlinden (Blue Antidote, Paris, France)
16.45 Prediction of mortality in older people, and individualized healthspan-promoting interventionsG. Fuellen (University of Rostock, Germany)
17.00 Artifi cial Intelligence for Aging Research and Drug DiscoveryA. Zhavoronkov (Insilico Medicine, Baltimore, United States)
25
Scientifi c Programme Wednesday, 21.09.2016
Prog
ram
me
Over
view
Floo
r Pla
n H
all 4
.0Po
ster
Over
view
Fl
oor P
lan
Hal
l 4.1
Exhi
bito
r Lis
tG
ener
al
Info
rmat
ion
Wel
com
eSc
ient
ifi c
Prog
ram
me
09.15 – 12.00 Best Practices in Clinical and Research Boston 1-3 Genomics and Data Warehousing
Chairs: C. Mason (Cornell University, New York, United States)J. Dudley (Icahn School of Medicine at Mount Sinai, New York, United States )D. Brown (Genome England, London, United Kingdom)D. Burgwinkel (Comptence Center Records Management, Zollikon, Switzerland)D. Domine (WEGA, Geneva, Switzerland)S. Wagers (BioSci Consulting, Maasmechelen, Belgium)
09.15 Introduction to Best PracticesB. Bhullar (BasePort, Basel, Switzerland)
09.45 The role of genomics in the future of precision medicine – the UK experienceR. Barker (Precision Medicine Catapult, Innovate UK, Swindon, United Kingdom)
10.15 Coffee break
11.00 A next-generation platform for clinical data integration and real-time monitoring of clinical trials: why data and user centricity mattersD. Agrafi otis (Covance, Princeton, United States)
11.30 Protecting Genomic DataJ.-P. Hubaux (EPFL, Lausanne, Switzerland)
14.30 – 17.15 Best practices in genomics data analysis Shanghai 1 for clinical and research applications
Chairs: J. Dudley (Icahn School of Medicine at Mount Sinai, New York, United States)C. Mason (Cornell University, New York, United States)
14.30 Cell Free, Cell-Bound, and Cross-Kingdom DNA BenchmarkingC. Mason (Cornell University, New York, United States)
15.00 The genetics clinics of the future: towards implementation of whole genome sequencing in diagnostic practiceI.J. Nijman (University Medical Center Utrecht, The Netherlands)
15.30 Coffee break
16.15 Biomarkers discovery and sample stratifi cation: a case studyN. Goffard (Illumina, Champagne-Ardenne, France)
16.45 Comprehensive molecular profi ling and mining of the bibliome for personalized treatment suggestions in cancerD. Stekhoven (ETH Zurich, Switzerland)
26
Scientifi c Programme Wednesday, 21.09.2016
14.30 – 17.15 Status and Future of (Standardized) Research Boston 1-3 Data Warehouses
Chair:D. Domine (WEGA, Geneva, Switzerland)
Co-Chair:S. Wagers (eTricks, Antwerp, Belgium)
14.30 To be announcedG. Landrum (Novartis, Basel, Switzerland)
14.50 Big data variety & veracity: the roche preclinical warehouseO. Roche (F. Hoffmann-La Roche Ltd, Basel, Switzerland)
15.10 Principles of research data managementM. de Francesco (UCB, Slough, United Kingdom)
15.30 Coffee break
16.15 Technical and legal requirements for data management in collaborative research projects: an example based on the IMI OncoTrack consortiumD. Henderson (Bayer Pharma AG, Berlin, Germany)
16.35 Mining a large-scale integrated data resource for target and lead discoveryJ.P. Overington (Stratifi ed Medical Ltd., London, United Kingdom)
16.55 Antimalarial drug discovery: the not-for-profi t PerspectiveP. Willis (Medecines for Malaria Venture (MMV), Geneva, Switzerland)
14.30 – 17.15 Best practices in data storage integrity Lima and security
Chairs: D. Burgwinkel (Comptence Center Records Management, Basel, Switzerland)D. Brown (Genome England, London, United Kingdom)
14.30 Blockchains as proof of data integrity in LifeScience and eHealthD. Burgwinkel (Information Governance Basel, Switzerland)
15.00 e-Estonia: confi dentiality, availability and integrity in a dynamic digital societyA. Piperal (Government of Estonia, Tallin, Estonia)
15.30 Coffee break
16.15 Ensuring Healthcare System Integrity with BlockchainI. Lohmus (Guardtime, Tallin, Estonia)
16.45 Unlocking the value of blockchain in healthcareA. Laeven (Amsterdam, Netherlands)
Workshops and Courses
12.15 – 13.15 Workshop: Strategic recalibration: Shanghai 1 What’s next for me?
Hosted by Grass & Partner AG
27
Scientifi c Programme Wednesday, 21.09.2016
Prog
ram
me
Over
view
Floo
r Pla
n H
all 4
.0Po
ster
Over
view
Fl
oor P
lan
Hal
l 4.1
Exhi
bito
r Lis
tG
ener
al
Info
rmat
ion
Wel
com
eSc
ient
ifi c
Prog
ram
me
Industry Symposia
12.15 – 13.15 Perkin Elmer Shanghai 2
Improved Assays for Cell Toxicity
Combining whole well and high content analysis with 2D and 3D cell culture
12.15 – 13.15 Molecular Devices Shanghai 3
Implement high-throughput 3D analysis and live-cell imaging applications for samples from subcellular structures to spheroids
Chair: G. Chandy (Molecular Devices, Sunnyvale, United States)
12.15 Revolutionary tools for acquiring and analyzing 3D data from high-throughput assaysG. Chandy (Molecular Devices, Sunnyvale, United States)
12.45 3D live-cell imaging applications: from subcellular structures to spheroidsC. Holz (Molecular Devices (Germany) GmbH, Biberach an der Riss, Germany)
12.15 – 13.15 Embassy of Italy in Bern - Cluster ALISEI Lima
What is happening behind the Alps: ALISEI and the Italian life science ecosystem
Chair: F. Conicella (Bioindustry Park Silvano Fumero/bioPmed cluster/ALISEI, Colleretto Giacosa (TO), Italy)
12.15 Welcome Italian Embassy
12.20 What is happening behind ALPES: ALISEI and the italian life science ecosystemF. Conicella (Bioindustry Park Silvano Fumero/bioPmed cluster/ALISEI, Colleretto Giacosa (TO), Italy
12.30 Creabilis: from an Italian idea to a European biotech companyS. Traversa (Creabilis, Colleretto Giacosa (TO), Italy)
12.40 Dompé drug Discovery: an innovative technology platform targeting membrane proteinsA. Aramini (Dompè, Milano, Italy)
12.50 It is possible to see: imaging technology applied to drug discovery and developmentV. Lorusso (Ephoran MIS, Colleretto Giacosa (TO), Italy)
13.00 Digital Health: Opportunities and Challenges Ahead for Research-intensive CompaniesM. Santoro (CAMELOT Biomedical Systems, Genova, Italy)
13.10 Q&A
28
Scientifi c Programme Thursday, 22.09.2016
Keynote
13.30 – 14.15 Welcome Words Boston 1-3
D. Gygax (FHNW, Muttenz, Switzerland)
Keynote Lecture 3
Increasing the predictive value of preclinical researchS. Silberberg (National Institute of Neurological Disorders and Stroke, NIH, Bethesda, United States)
Scientifi c Forum
09.15 – 17.15 Basel Microfl uidics Workshop 2016 Opening/ Delhi Key Note session
Chairs: F. Käser (BaselArea.swiss, Basel, Switzerland)H. Knapp (CSEM, Alpnach, Switzerland)
09.15 Welcome & Introduction
09.30 Elevator-Pitches given from the organising Partners
09.50 “Lab on chip” – microfl uidics, history, “organ on chip” and biomimetic channel networksA. Manz (KIST Europe, Universität des Saarlandes, Saarbrücken, Germany)
10.15 Coffee break
11.00 Insights, opportunities and risks in the production of microfl uidic devicesC. Denier (Weidmann Medical Technology, Rapperswil, Switzerland)
11.15 Spark assisted chemical engraving (SACE), an innovative technology for glass micromachiningC. Goyer (Posalux SA, Biel/Bienne, Switzerland)
11.30 Microfl uidic platform technologies for chemistry and life science applicationsM. Brivio (Micronit Microfl uidics, Enschede, The Netherlands)
11.45 Moderated Panel Discussion with the PresentersModerator: H. Knapp (CSEM, Alpnach, Switzerland)
14.30 Applying System Engineering and Microfl uidics in Next Generation SequencingK. Lutze (Qiagen, Hombrechtikon, Switzerland)
14.45 Nanofl uidic-based biosensors allow quantifi cation of circulating IgE from a drop of whole blood in 5 minutesI. Märki (Abionic SA, Lausanne, Switzerland)
29
Scientifi c Programme Thursday, 22.09.2016
Prog
ram
me
Over
view
Floo
r Pla
n H
all 4
.0Po
ster
Over
view
Fl
oor P
lan
Hal
l 4.1
Exhi
bito
r Lis
tG
ener
al
Info
rmat
ion
Wel
com
eSc
ient
ifi c
Prog
ram
me
15.00 The automated use of MagSiMUS technology in drug discovery screening processesP. van Driessche (MagnaMedics Diagnostics BV, Geleen, The Netherlands)
15.15 Moderated Panel Discussion with the PresentersModerator: M. Collasius (Qiagen, Hombrechtikon, Switzerland)
15.30 Coffee break
16.15 Microfl uidic synthesis of targeted drugsW. van Hoeve (Tide Microfl uidics B.V., Enschede, The Netherlands)
16.30 Development and manufacturing of sustained release microspheres with INFINITY Microfl uidicR. de Bruin (Emultech, Einhoven, Netherlands)
16.45 Organs-on-chip technology for preclinical testingO.T. Guenat (AlveoliX AG, Berne, Switzerland)
17.00 Moderated Panel Discussion with the PresentersModerator: J. Lötters (Bronkhorst High-Tech, Ruurlo, Netherlands)
09.15 – 12.00 Molecular Diagnostics brought Shanghai 1 by NTN Swiss Biotech
Chairs: E. Kübler (FHNW, Muttenz, Switzerland)F. Baumberger (BFH, Berne, Switzerland)D. Gygax (FHNW, Muttenz, Switzerland)
09.15 The future of Personalized Healthcare: the importance of diagnostics and molecular information from an industry perspectiveM. Venturi (Hoffmann La Roche, Basel, Switzerland)
09.45 Biomolecular computing circuits for diagnostics and therapyY. Benenson (ETH Zurich, Basel, Switzerland)
10.15 Coffee break
11.00 Biomarker Discovery and Effi cient Profi ling Using Whole Transcriptome or Targeted TempO-Seq Gene Expression AssaysH. Van Steenhouse (BioSpyder Technologies, San Diego, United States)
11.30 Innovations in the molecular diagnosis of TB and drug resistance – current and future perspectives C. Gilpin (WHO, Geneva, Switzerland)
30
Scientifi c Programme Thursday, 22.09.2016
09.15 – 17.15 Synthetic Biology Shanghai 2
Chairs:M. Fussenegger (ETH Zurich, Basel, Switzerland)S. Reddy (ETH Zurich, Basel, Switzerland)
09.15 Artifi cial metalloenzymes for synthetic biology purposesT.R. Ward (University of Basel, Switzerland)
09.45 Reimagine SequenceSpaceTMR. Kettleborough (Twist Bioscience, St Neots, United Kingdom)
10.00 Coffee break
11.00 Remote-controlled Mammalian Cells for Biomedical ResearchW. Weber (University Freiburg, Germany)
11.30 Make connections for life: superglue from fl esh-eating bacteria to create teams for control of cancer cell and immune signallingM. Howarth (University of Oxford, United Kingdom)
14.30 Harnessing the power of natural immune equilibrium to develop solutions for antigen-specifi c toleranceS. Kontos (Anokion, Lausanne, Switzerland)
15.00 How to improve your CRISPR/ Genome Editing experiments M. Cannieux (Integrated DNA Technologies, Leuven, Belgium)
15.30 Coffee break
16.15 Towards the expansion of the natural structural repertoire for the design of functional proteinsB. Correia (Anokion, Lausanne, Switzerland)
16.45 Panel discussion on synthetic biology impact on medicine
31
Scientifi c Programme Thursday, 22.09.2016
Prog
ram
me
Over
view
Floo
r Pla
n H
all 4
.0Po
ster
Over
view
Fl
oor P
lan
Hal
l 4.1
Exhi
bito
r Lis
tG
ener
al
Info
rmat
ion
Wel
com
eSc
ient
ifi c
Prog
ram
me
09.15 – 17.15 Aging & Drug Discovery Shanghai 3
Chairs: A. Zhavoronkov (Insilico Medicine, Baltimore, United States)B. Bhullar (BasePort, Basel, Switzerland)B. Kennedy (Buck Institute for Research on Aging, Novato, United States)
09.15 Genomic approaches for discovery of lifespan interventionsV.N. Gladyshev (Brigham and Women‘s Hospital, Harvard, Boston, United States)
09.45 Integrated Biomarkers of AgingA. Moskalev (Russian Academy of Sciences, Syktyvkar, Russian Federation)
10.15 Coffee break
11.00 Targeting the stem cell niche to restore muscle regeneration in agingJ. Feige (Nestle Institute of Health Sciences, Lausanne, Switzerland)
11.30 The global healthspan extension initiative: selective approaches to validated technologies and integrated biomarkers Z.S. Zhumadilov (Nazarbayev University, Astana, Kazakhstan)
11.45 The main features of Healthcare System Development dedicated for longevity in KazakhstanV. Benberin (Research Institute on Gerontology and Anti-aging Medicine of the Republic of Kazakhstan, Astana, Kazakhstan)
14.30 The regulatory landscape of APP processingL.M. Camargo (UCB, Cambridge, United States)
15.00 To be announced
15.30 Coffee break
16.15 Intervention in accelerated agingM. Scheibye-Knudsen (University of Copenhagen, Copenhagen, Denmark)
16.45 Panel Discussion: Current Issues in Aging & LongevityChair: M. Blagosklonny (Aging-US, Buffalo, United States)
32
Scientifi c Programme Thursday, 22.09.2016
09.15 – 17.15 Synergy Forum Lima
Chairs: G. Ulrich-Merzenich (University Clinic Bonn, Germany)H. Schweim (University of Bonn, Germany)
09.15 Methods to assess SynergyG. Ulrich-Merzenich (University Clinic Bonn, Germany)
09.45 In vitro therapeutic synergy and iterative search for promising drug combinationsM. Gustafsson (Uppsala University, Sweden)
10.15 Coffee break
11.00 Mass-action law algorithms for quantitative simulation of interactions of multiple drug combinationsT.-C. Chou (Memorial Sloan Kettering Cancer Centre, New York, United States)
11.30 Discussion
14.30 Synergistic blockade of ErbB receptors and downstream signaling overcomes adaptive response in ErbB2-addicted tumorsR. Tamaskovic (University of Zurich, Switzerland)
15.00 A 3D image-based phenotypic screen of bi-specifi c antibodies targeting stem cells in a panel of patient derived colon carcinoma organoidsL. Price (OcellO BV, Leiden, The Netherlands)
15.30 Coffee break
16.15 Large-scale network analysis of an immune responseE. Miho (ETH Zurich, Switzerland)
16.30 Drug regulatory aspects for combination treatments: regulatory perspectiveH. Schweim (University of Bonn, Germany)
16.45 Massive parallel GPU accelerated DeepLearning in the cloud- the next generation of machine learning algorithms is preparing to take over the AI ecosystemR. Kienzler (IBM Watson, Zurich, Switzerland)
33
Scientifi c Programme Thursday, 22.09.2016
Prog
ram
me
Over
view
Floo
r Pla
n H
all 4
.0Po
ster
Over
view
Fl
oor P
lan
Hal
l 4.1
Exhi
bito
r Lis
tG
ener
al
Info
rmat
ion
Wel
com
eSc
ient
ifi c
Prog
ram
me
09.15 – 12.00 Best practices in genomics data analysis for Kairo 1-2 clinical and research applications
Chairs: J. Dudley (Icahn School of Medicine at Mount Sinai, New York, United States)C. Mason (Cornell University, New York, United States)
09.15 Integrative NGS for Drug Discovery and Precision MedicineJ. Dudley (Icahn School of Medicine at Mount Sinai, New York, United States)
09.45 To be announced
10.15 Coffee break
11.00 NGS in routine molecular diagnostic: status quo and prospectiveL. Quagliata (Universitätsspital Basel, Switzerland)
11.30 Open Forum
09.15 – 12.10 Status and Future of (Standardized) Research Boston 1-3 Data Warehouses
Chair: D. Domine (WEGA, Geneva, Switzerland)Co-Chair:S. Wagers (eTricks, Antwerp, Belgium)
09.15 The open PHACTS foundation – open semantic data services for drug discoveryB. Williams-Jones (Open PHACTS Foundation, Cambridge, United Kingdom)
09.35 eTRIKS: Reducing the effort needed to preserve and explore translational research dataS. Wagers (eTricks, Antwerp, Belgium)
09.55 Break Down The Firewall Between Data And Discovery with PerkinElmer SignalsC. Gänzler (PerkinElmer, Stuttgart, Germany)
10.15 Coffee break
11.00 BioStudies database – fi lling in the gaps between publications and structured datasetsU. Sarkans (EMBL-EBI, Cambridge, United Kingdom)
11.20 Optimise end-to-end bioprocess projects: from cell line development through to formulations and stability testingP.D. Gouldson (IDBS, Guildford, United Kingdom)
11.50 The roadmap and future of the tranSMART knowledge management / data warehousing platform K. Nangle (Transmart Foundation, Mannheim, Germany)
34
Scientifi c Programme Thursday, 22.09.2016
09.15 – 12.00 Best practices in data storage integrity Darwin and security
Chairs: D. Burgwinkel (Comptence Center Records Management, Basel, Switzerland)D. Brown (Genome England, London, United Kingdom)
09.15 Optimal secure storage model for genomic dataB. Bhullar (BasePort, Basel, Switzerland)
09.45 Storage for InforgsH. Mangalam (University of California Irvine, United States)
10.15 Coffee break
11.00 Management and Integration of data from multiple sourcesA. Ahonen-Bishopp (BC Platforms, Basel, Switzeland)
11.30 Data storage for 100,000 Genome ProjectD. Brown (Genome England, London, United Kingdom)
14.30 – 17.15 Best Practices in Clinical and Research Boston 1-3 Genomics and Data Warehousing
Chairs: C. Mason (Cornell University, New York, United States)J. Dudley (Icahn School of Medicine at Mount Sinai, New York, United States )D. Brown (Genome England, London, United Kingdom)D. Burgwinkel (Comptence Center Records Management, Zollikon, Switzerland)D. Domine (WEGA, Geneva, Switzerland)S. Wagers (BioSci Consulting, Maasmechelen, Belgium)
14.30 Genome Data Analysis SummaryC. Mason (Cornell University, New York, United States)J. Dudley (Icahn School of Medicine at Mount Sinai, New York, United States)
15.00 Data Warehousing SummaryD. Domine (WEGA, Geneva, Switzerland)S. Wagers (eTricks, Antwerp, Belgium)
15.30 Coffee break
16.15 Data storage integrity and security summaryD. Burgwinkel (Competence Center Records Management, Zollikon, Switzerland)D. Brown (Genome England, London, United Kingdom)
16.45 The barriers to the delivery of Precision MedicineZ. Khayat (MaRS EXCIT, Toronto, Canada)
35
Scientifi c Programme Thursday, 22.09.2016
Prog
ram
me
Over
view
Floo
r Pla
n H
all 4
.0Po
ster
Over
view
Fl
oor P
lan
Hal
l 4.1
Exhi
bito
r Lis
tG
ener
al
Info
rmat
ion
Wel
com
eSc
ient
ifi c
Prog
ram
me
14.30 – 17.15 Jumpstarting Innovation – Early stage Kairo 1-2 investing, start-up-incubation and how to enable the future generation of biotech innovators
Chairs: O. Gusyatiner (IF Lausanne, Switzerland)M. Fankhauser (IF Lausanne, Switzerland)S. Emmerth (BaselArea.swiss, Basel, Switzerland)
14.30 Opening remarks: Innovation Forum LausanneO. Gusyatiner (IF Lausanne, Switzerland)M. Fankhauser (IF Lausanne, Switzerland)C. Ciller (IF Lausanne, Switzerland)M. Broggi (IF Lausanne, Switzerland)
14.40 Cell to Cellestia Biotech AG: Transition from basic research to a Biotech companyR. Lehal (Cellestia Biotech, Lausanne, Switzerland)
14.55 Organoids for high-throughput screeningsS. Höhnel (SunBioscience, Lausanne, Switzerland)N. Brandenberg (SunBioscience, Lausanne, Switzerland)
15.10 JLINX: Accelerating early-stage transformative innovation – a partnership between J&J Innovation, Janssen & BioQube VenturesK. Hertogs (Johnson & Johnson Innovation, London, United Kingdom)N. Vandervelpen (BiQube Ventures, Zurich, Switzerland)
15.30 Coffee break
16.15 Biotech Beyond the Third DimensionK. Schmidt (CellSpring, Zurich, Switzerland)
16.30 Anokion: Launching a Platform TechnologyS. Kontos (Anokion, Lausanne, Switzerland)
16.50 Institutionalized generation of disruptive biotech venturesJ. Mata-Fink (Flagship Ventures, Boston, United States)
17.10 Closing remarks: Innovation Forum LausanneO. Gusyatiner (IF Lausanne, Switzerland)M. Fankhauser (IF Lausanne, Switzerland)C. Ciller (IF Lausanne, Switzerland)M. Broggi (IF Lausanne, Switzerland)
36
Scientifi c Programme Thursday, 22.09.2016
Workshops and Courses
12.15 – 13.15 Workshop: Be on brand – in your resume, Shanghai 1 during an interview, in daily life
Hosted by Grass & Partner AG
Poster Award
The award ceremony will take place on Thursday, 22 September 2016 before the keynote speaker Dr. Shai Silberberg in room Boston 1-3.
37
Prog
ram
me
Over
view
Floo
r Pla
n H
all 4
.0Sc
ient
ifi c
Prog
ram
me
Post
erOv
ervi
ewFl
oor P
lan
Hal
l 4.1
Exhi
bito
r Lis
tG
ener
al
Info
rmat
ion
Wel
com
e
Poster Overview (Exhibition, Hall 4.1)
Post
erOv
ervi
ewPo
ster
Over
view
Bodendosen u. Medienanschlüsse mit Anschlussmöglichkeiten für:
Elektro
Sanität
Torschaltkasten UK ca. 1.30m
Steuerkasten UK ca. 1.30m
Halleninfosäule
Plakatwand
Recycling-Container
Internes Hallentelefon
Notausgang
Telefonkabine
Handtaster Brandmelde Anlage
Feuerlöschposten
Handfeuerlöscher Wasser-, Elektro- und Telefonanschlüsse
Elektro- und Telefonanschlüsse
Detail
Holzrückwand von 3.00 m Höhe.
Elekroverteilkasten
Stände entlang den Hallenwände
Warenlift
Medienpunktraster
Stützenraster
Bodenbelastung
Nutzhöhe der Halle / Max. Bauhöhe
Hallenfläche
Grundriss, Geschoss
Sicherheitsanlagen
Nutzlast 6'000 KgLxBxH: 6.50x2.45x3.20 m
1 Medienpunkt pro 15m2
600 Kg/m2 (Ausnahmen im Plan eingezeichnet)
ca. 80 x 80 m, 3 Geschosse
müssen zugänglich sein.
haben eine
(z.B. Feuerlöschposten) und
4'100 m2
11.4x11.4 m
Aufhängungen sind teilweise mittels in derBetondecke eingelassenen M10 Hülsen möglich.
3.50 m (Randstände 3.00 m)Ausnahmen im Plan eingezeichnet
Articles can be suspended at some points fromM10 sockets in the concrete ceiling
11,40
3,80 3,80 3,80
11,40
3,80 3,80 3,80
Floor sockets and media connections for connecting up:
Electricity
Medical service
Gate-operating box,
Hall information pillar
Poster wall
Recycling container
Internal hall telephone
Emergency exit
Telephone booth
Pushbutton for fire alarm system
Fire point
Hand-held fire extinguisher Water, electricity and telephone connections
Electricity and telephone connections
rear wooden wall 3.00m high
electrical distribution boxes
Stands along the hall walls
Goods lift
Media point grid
Pillar grid
Floor loading
Effective height of Hall / max. construction height
Hall surface area
Floor plan, storey
Safety facilities
Maximum permitted load: 6000 kgLxWxH: 6.50x2.45x3.20 m
1 media point per 15m2
600 Kg/m2 (Exceptions drawn in on plan)
3.50 m (Edge stands 3.00 m)
ca. 80 x 80 m, 3 Storeys
must be accessible
have a
(e.g. fire points) and
11.4x11.4 m
4100 m2
bottom edge approx. 1.30 m
Exceptions drawn in on plan
85
42.5 42.5
45 202095
Covering on hall pillar 3.00 m high
55
47.5 47.5
Nr.
Nr.
Pillar detail
4585
42.5 42.5
45 202095
55
47.5 47.5
45
StützendetailHallenstützenverkleidung 3.00m hoch
Detail
3m 5m 7m
4m 6m 8m
1m
2m
Aisle
D
Aisle
AAisle
BAisle
CAisle
D
Aisle
AAisle
BAisle
CAisle
D
Aisle
BAisle
CAisle
D
Aisle
AAisle
B
@-Corner
Coffee 1
From MainEntrance
To MainEntrance
Coffee 2
3x2
4x33x2 3x2
3x3
4x6
3x4
3x4 - 1m23x4
3x4
4x6
4x23x4
3x3
3x3
3x3
3x4.5
3x4
2x4
4x5
3x2
3x3
3x33x2
3x3
3x3
2x3
2x3
3x2
3x3
4x6
5x4
4x3
3x3
3x3
3x3
4x7 - 4m2
2x3
2x3
2x3
3x2 3x2 4x2
3x2
2x3
3x2
3x3
3x3 6x3+3x1
3x4
3x4
To / FromLecture Halls
2x4
3x5
3x23x2
Coffee 3
2x44x2
3x2
3x2
2x3
3x4
3x4
3x4
3x3
4x2
4x2
3x7
3x4
P001P012
P013 P024
P025P046
P047 P058
P059P081P082 P093
P094
P117P106P105
P120 P118
3x2
2x2
2x2
2x3
2x3
3x2
3x2
3x3
3x3
7x6
4x4
4x3
StageInnovation
Village
3x2 3x2
2x3
2x2
3x2 3x2
P121 P129
P138 P130
P150
P151
P139
Bodendosen u. Medienanschlüsse mit Anschlussmöglichkeiten für:
Elektro
Sanität
Torschaltkasten UK ca. 1.30m
Steuerkasten UK ca. 1.30m
Halleninfosäule
Plakatwand
Recycling-Container
Internes Hallentelefon
Notausgang
Telefonkabine
Handtaster Brandmelde Anlage
Feuerlöschposten
Handfeuerlöscher Wasser-, Elektro- und Telefonanschlüsse
Elektro- und Telefonanschlüsse
Detail
Holzrückwand von 3.00 m Höhe.
Elekroverteilkasten
Stände entlang den Hallenwände
Warenlift
Medienpunktraster
Stützenraster
Bodenbelastung
Nutzhöhe der Halle / Max. Bauhöhe
Hallenfläche
Grundriss, Geschoss
Sicherheitsanlagen
Nutzlast 6'000 KgLxBxH: 6.50x2.45x3.20 m
1 Medienpunkt pro 15m2
600 Kg/m2 (Ausnahmen im Plan eingezeichnet)
ca. 80 x 80 m, 3 Geschosse
müssen zugänglich sein.
haben eine
(z.B. Feuerlöschposten) und
4'100 m2
11.4x11.4 m
Aufhängungen sind teilweise mittels in derBetondecke eingelassenen M10 Hülsen möglich.
3.50 m (Randstände 3.00 m)Ausnahmen im Plan eingezeichnet
Articles can be suspended at some points fromM10 sockets in the concrete ceiling
11,40
3,80 3,80 3,80
11,40
3,80 3,80 3,80
Floor sockets and media connections for connecting up:
Electricity
Medical service
Gate-operating box,
Hall information pillar
Poster wall
Recycling container
Internal hall telephone
Emergency exit
Telephone booth
Pushbutton for fire alarm system
Fire point
Hand-held fire extinguisher Water, electricity and telephone connections
Electricity and telephone connections
rear wooden wall 3.00m high
electrical distribution boxes
Stands along the hall walls
Goods lift
Media point grid
Pillar grid
Floor loading
Effective height of Hall / max. construction height
Hall surface area
Floor plan, storey
Safety facilities
Maximum permitted load: 6000 kgLxWxH: 6.50x2.45x3.20 m
1 media point per 15m2
600 Kg/m2 (Exceptions drawn in on plan)
3.50 m (Edge stands 3.00 m)
ca. 80 x 80 m, 3 Storeys
must be accessible
have a
(e.g. fire points) and
11.4x11.4 m
4100 m2
bottom edge approx. 1.30 m
Exceptions drawn in on plan
85
42.5 42.5
45 202095
Covering on hall pillar 3.00 m high
55
47.5 47.5
Nr.
Nr.
Pillar detail
4585
42.5 42.5
45 202095
55
47.5 47.5
45
StützendetailHallenstützenverkleidung 3.00m hoch
Detail
3m 5m 7m
4m 6m 8m
1m
2m
Aisle
D
Aisle
AAisle
BAisle
CAisle
D
Aisle
AAisle
BAisle
CAisle
D
Aisle
BAisle
CAisle
D
Aisle
AAisle
B
@-Corner
Coffee 1
From MainEntrance
To MainEntrance
Coffee 2
3x2
4x33x2 3x2
3x3
4x6
3x4
3x4 - 1m23x4
3x4
4x6
4x23x4
3x3
3x3
3x3
3x4.5
3x4
2x4
4x5
3x2
3x3
3x33x2
3x3
3x3
2x3
2x3
3x2
3x3
4x6
5x4
4x3
3x3
3x3
3x3
4x7 - 4m2
2x3
2x3
2x3
3x2 3x2 4x2
3x2
2x3
3x2
3x3
3x3 6x3+3x1
3x4
3x4
To / FromLecture Halls
2x4
3x5
3x23x2
Coffee 3
2x44x2
3x2
3x2
2x3
3x4
3x4
3x4
3x3
4x2
4x2
3x7
3x4
P001P012
P013 P024
P025P046
P047 P058
P059P081P082 P093
P094
P117P106P105
P120 P118
3x2
2x2
2x2
2x3
2x3
3x2
3x2
3x3
3x3
7x6
4x4
4x3
StageInnovation
Village
3x2 3x2
2x3
2x2
3x2 3x2
P121 P129
P138 P130
P150
P151
P139
Poster Plan – Regular Posters
Poster Plan – Late Breaker Posters
Overview Poster Area
Aisle
D
Aisle
AAisle
BAisle
CAisle
D
Aisle
AAisle
BAisle
CAisle
D
Aisle
BAisle
CAisle
D
Aisle
AAisle
B
@-Corner
Coffee 1
From MainEntrance
To MainEntrance
Coffee 2
To / FromLecture Halls
Coffee 3
StageInnovation
Village
Regular Posters
Late Breaker Posters
FromLecture Halls
ToLecture Halls
38
Floor Plan Hall 4.1 (Exhibition)
Aisle
D
Aisle
AAisle
BAisle
CAisle
D
Aisle
AAisle
BAisle
CAisle
D
Aisle
BAisle
CAisle
D
Aisle
AAisle
B
@-Corner
Coffee 1
From MainEntrance
To MainEntrance
Coffee 2
To / FromLecture Halls
Coffee 3
StageInnovation
Village
Regular Posters
Late BreakerPosters
FromLecture Halls
ToLecture Halls
39
Prog
ram
me
Over
view
Floo
r Pla
n H
all 4
.0Sc
ient
ifi c
Prog
ram
me
Post
erOv
ervi
ewFl
oor P
lan
Hal
l 4.1
Exhi
bito
r Lis
tG
ener
al
Info
rmat
ion
Wel
com
eFl
oor P
lan
Hal
l 4.1
Floo
r Pla
n H
all 4
.1
Floor Plan Hall 4.1 (Exhibition)
Aisle
D
Aisle
AAisle
BAisle
CAisle
D
Aisle
AAisle
BAisle
CAisle
D
Aisle
BAisle
CAisle
D
Aisle
AAisle
B
@-Corner
Coffee 1
From MainEntrance
To MainEntrance
Coffee 2
To / FromLecture Halls
Coffee 3
StageInnovation
Village
Regular Posters
Late BreakerPosters
FromLecture Halls
ToLecture Halls
40
Exhibitor List
Name of Exhibitor Booth4titude B16ACEA Biosciences Inc. C34Active Motif A23Agilent C52Agilent Technologies C34(Seahorse XF products)Analytic Jena B54Andreas Hettich GmbH B46Andrew Alliance SA A48Aptuit (Switzerland) AG D 15Artel C54BD Life Science C64Beckman Coulter D43BioLamina B66BioNex Solutions C34Biotage AB A42Bio-Techne A46BioTek Instruments GmbH D36BioVariance GmbH D61Basel Life Science Week 2017 A35BlueCatBio B43BMG Labtech A24Bruker-Physik GmbH B47Bucher Biotec C34Cellular Dynamics B45Chemspeed D26Cisbio B55Cognex D45Corning C45Covaris Ltd. C62Credimex AG A45CSEM A43DeNovix Inc C34Dispendix GmbH D46Ectica Technologies D70Embassy of Italy in Bern – A37Cluster ALISEICzech Republic A31EQUIcon Software C46Essen Bioscience B64Euresearch D50Eurogentec D51Fluxion Biosciences C34Formulatrix B52Fritz Gyger AG A53/ C34GC biotech B.V. C41GORYO Chemical Inc. D53Hamamatsu A40Hamilton C53
Name of Exhibitor BoothHuawei D65iba life sciences D13InSCREENeX GMBH D58Integra B40Integrated DNA Technologies D22BVBAIntelliCyt Corporation C34Kommission für Technologie D50und Innovation KTIKoNECT C60Lab Services D41Labcyte A49Labcyte A51LC Patents D56LiCONiC AG D57Life & Brain GmbH C44Lifeonics C34Logos Biosystems C34Luminex A39MaxWell Biosystems AG D52MDPI AG, Multidisciplinary D60Digital Publishing InstitutemilliDrop D54Miltenyi Biotec C50Mimetas B.V. C56Molecular Devices A26Molecular Sensing GmbH A52MyCartis B14Nano Temper D11OcellO B.V. D62OMass Technologies Ltd D44Perkin Elmer C61Pivot Park Screening Centre C58Quantifoil B50ReproCELL B44SAL Scientifi c Limited D67Sartorius Stedim Biotech C43Seyonic A47SILA A45Sphere Fluidics C34SUN bioscience D42Susos AG A25Switzerland Innovation Park D50Basel AreaThermo Fisher Scientifi c C40Titian Software Ltd. B24Twist Bioscience B42Unchained Labs B26Xavo B62Zinsser Analytic B41
As per 22 August 2016
41
Prog
ram
me
Over
view
Floo
r Pla
n H
all 4
.0Sc
ient
ifi c
Prog
ram
me
Post
erOv
ervi
ewFl
oor P
lan
Hal
l 4.1
Exhi
bito
r Lis
tG
ener
al
Info
rmat
ion
Wel
com
eEx
hibi
tor L
ist
Exhi
bito
r Lis
tG
ener
al
Info
rmat
ion
Gen
eral
In
form
atio
n
General Information
AbstractsAll accepted abstracts are visible in the detailed interactive programme on the congress website (www.basellife.org) and on the Science Publication Network (SPN, www.sci-pub.net).
ATMAn ATM is located outside the Congress Center Basel on the left hand of the main entrance. VISA and MasterCard are accepted.
BadgesFor admission to all scientifi c forums your personal badge is required. You may attend any forum even if you did not register for it online (except Career Work-shops on Monday). Please wear your badge at all times. CHF 30 will be charged for replacement of a lost badge.
CloakroomA cloakroom is available on the ground fl oor during the secretariat opening hours and can be used free of charge. Please note that the cloakroom is unguarded.
Exhibition opening hoursTuesday, 20 September 2016 08.45 – 18.00Wednesday, 21 September 2016 08.45 – 17.00Thursday, 22 September 2016 08.45 – 16.30
InsuranceThe meeting organiser cannot accept liability for personal injuries sustained, or for loss or damage of property, either during, or as a result of the meeting. Please check the validity of your insurance.
Internet cornerSeveral internet terminals are located in the exhibition area and are available to all congress participants during the opening hours of the exhibition. An attendee list (names and provenance) can be viewed at the internet corner.
Coffee & lunchA light lunch (e.g. salad and soup) is served between 12.00 and 13.30 in the exhibition Hall 4.1 free of charge (on a fi rst-come, fi rst-served basis). Coffee is available throughout the day in the exhibition hall 4.1 between 08.45 and 17.00.
Networking Events
Welcome ReceptionTuesday, 20 September 2016 17.15–18.00 (Hall 4.1)
Poster Session and ApéroWednesday, 21 September 2016 17.15–18.00 (Hall 4.1)
42
General Information
PostersThe poster exhibition is located in Hall 4.1.
Poster session Poster mounting Poster removalWednesday,
21 September 201617.00 – 18.00
Tuesday,20 September 2016
09.00 – 10.00
Thursday,22 September 2016
16.00 – 17.00
Authors are kindly asked to be present at their posters during the poster session and the times shown above. All authors are required to mount and remove their posters at the above mentioned times.
Poster AwardThe Steering Committee is proud to grant the Poster Award at Basel Life Science Week 2016! This annual programme serves to highlight and reward high level presentations. Eligible candidates are all poster presenters at the Basel Life Sci-ence Week 2016. Award comprises CHF 300 for the winner, CHF 200 for the 2nd and CHF 100 for the 3rd place.
Judging and selection will take place at BLSW 2016 and is handled by the BLSW poster award selection committee.
The award ceremony will take place on Thursday, 22 September 2016 before the keynote speaker Dr. Shai Silberberg in room Boston 1–3.
Registration / Secretariat Opening HoursMonday, 19 September 2016 08.45 – 16.00Tuesday, 20 September 2016 08.15 – 17.30Wednesday, 21 September 2016 08.30 – 17.30Thursday, 22 September 2016 08.30 – 17.15
ResponsibilityThe participants acknowledges that he/she has no right to lodge damage claims against the organisers should the holding of the conference be hindered or pre-vented by political events (such as acts of terrorism, danger of hostility, war etc.) or by unexpected political or economical events or generally “force majeure”, or should the non-appearance of speakers or other reasons necessitate programme changes. With registration, the participant accepts this proviso.
Speakers’ Service Centre (SSC)The SSC is located close to all lecture halls. All speakers are kindly asked to hand in their PowerPoint presentation at the SSC at least 1 hour before the start of the session.
VenueThe conference takes place at the Congress Center Basel. Messeplatz 21CH-4058 BaselPhone: +41 58 206 28 20 (onsite)www.congress.ch
WLANFree wireless-LAN is available throughout the whole Congress Center Basel.
Save the date
BLSW 2017 11 – 15 September 2017
MipTec exhibition12 – 14 September 2017
Basel Life Science Week 2016 Day One – The Future of Health:
19 September 2016
Basel Life Science Week: 19 – 22 September 2016
MipTec Exhibition: 20 – 22 September 2016
ILMAC: 20 – 23 September 2016
Medtech & Pharma Platform: 22 – 23 September 2016
2017 Sept 1 1–15Science Week Leading in Europe
The International Life Science
Exhibition
Sept 12–14
Visit us a
t our
Booth C
34 Visit
us at our
Booth C
34
YourResearch
Leaping Forward
Immunotherapy Single Cell Fastest Sample Transfer Non Contact Nano Liter Dispensing Metabolic Phenotyping Benchtop Flow Cytometry Cell Analysis under Physiological Flow Suspension Cell Culture Growth Innovative Screening Solutions
your premier life science solutions provider www.bucher.ch
Inserat 2016.indd 1 15.08.16 14:32